Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-03-13
2000-05-30
Woodward, Michael P.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 17, 514 21, 530329, 530330, 435 681, A61K 3801, A61K 3808
Patent
active
060691298
ABSTRACT:
The present invention is directed to a formulation or composition which is used to enhance the softness, elastin, or appearance of tissue by increasing the endogenous elastin production. Specifically, the present invention is directed to a composition formulated from the products of thermolysin digestion which are filtered through a 10,000 molecular weight cutoff device, which may be dried to have a formulation which contains 90% or greater of peptides having a molecular weight lower than 10,000 Da. This formulation is preferably applied to human skin in a cosmetic or therapeutic formulation and results in enhanced elasticity of the skin.
REFERENCES:
patent: 4327078 (1982-04-01), Charlet et al.
patent: 4474763 (1984-10-01), Lubowe
patent: 4591501 (1986-05-01), Cioca
patent: 4659740 (1987-04-01), Usher
patent: 4963656 (1990-10-01), Mitani
patent: 5017691 (1991-05-01), Lee
patent: 5079003 (1992-01-01), Scaffidi et al.
patent: 5223420 (1993-06-01), Rabaud et al.
patent: 5523291 (1996-06-01), Janzen et al.
patent: 5648209 (1997-07-01), Avrameas et al.
Hieber, A. D. et al. Detection of Elastin in the Human Fetal Membranes: Proposed Molecular Basis for Elasticity; Placenta; vol. 18; pp. 301-312; 1997.
Gibson, M. A. et al. Further Characterization of Proteins Associated with Elastic Fiber Microfibrils Including the Molecular Cloning of MAGP-2 (MP25); The Journal of Biological Chemistry; vol. 271, No. 2. pp. 1096-1103; Jan. 12, 1996.
Price, L. S. C. et al. Valyl-Alanyl-Prolyl-Glycine (VAPG) Serves as a Quantatative Marker for Human Elastins; Matrix; vol. 13. pp. 307-311; 1993.
Blankenship, J. W. et al. Oxysterol Incorporation Into Rat Aorta Resulting in Elastin Compositional Changes; Lipids; vol. 26, No. 5; pp. 381-384; 1991.
Sandberg, L. B. et al. Quantitation of Elastin in Tissues and Culture: Problems Related to the Accurate Measurement of Small Amounts of Elastin With Special Emphasis on the Rat; Connective Tissue Research; vol. 25, pp. 139-148; 1990.
Sandberg, L. et al. Structural Guidelines for an Acceptable Elastin and Tropoelastin: Application Towards Quantitation of Elastin Accumulation in Tissue Culture; Elastin: Chemical and Biological Aspects (Reprinted); pp. 24-44; 1990.
Sandberg, L. B. et al. Quantitation of Elastin Through Measurement of Its Pentapeptide Content; Biochemical and Biophysical Research Communications; vol. 136, No. 2. pp. 672-678; Apr. 29, 1986.
Database CaPlus, AN 108:167920. Bayer et al. Z. Naturforsch., C: Biosci, 42(4), 455-60), Apr. 1987.
Hunninghake et al. Science, 212, 925-927, May 1981.
Database Caplus, DN 127:219499. Morrelli et al. J. Pept. Res., 49 (6), 429-499, Jun. 1997.
Database Caplus, DN 122:102414. Bisaccia et al. Int, J. Pept. Res, 44, 332-341, Apr. 1994.
Mitts Thomas F.
Roos Philip J.
Sandberg Lawrence B.
Borin Michael
Miller Raymond A.
MRS, LLC
Woodward Michael P.
LandOfFree
Elastin derived composition and method of using same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Elastin derived composition and method of using same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Elastin derived composition and method of using same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1910475